BioSpace News Archive

Urology Disorders are on a rise and that is leading the global urology devices market on an upward growth curve.

Transparency Market Research has published a new report titled, “Cardiac Arrest Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”.

Companies and the academia engaged in reprogramming and generation of human-induced pluripotent stem cells are leveraging the incredible potential in regenerative medicine.

The global epilepsy therapeutics market was valued at US$ 12.9 Bn in 2018.

The global eye care supplements market is majorly growing due to growth in the demand for over-the-counter drugs that are aimed to promote self-care.

Genespire, a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, announced today the successful close of a €16M Series A financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan

PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive, in-home device for treating Parkinson’s Disease.

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced the Accreditation Committee of the College of American Pathologists (CAP) has awarded re-accreditation to the Personalis Clinical Laboratory, Menlo Park, California based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

AIS Healthcare is leveraging its industry-leading 503A compounding facilities to help address a national medication shortage while continuing to provide existing patients with medications of the highest quality and sterility.

BioStem Technologies, Inc. a leading life sciences company specializing in perinatal tissue-based allografts for use in regenerative therapies, announced a corporate update on the Company’s direction..